Aquestive Therapeutics Inc

NASDAQ:AQST   3:59:57 PM EDT
3.35
0.00 (0.00%)
Earnings Announcements

Aquestive Therapeutics- QTRLY Net Loss Per Share - Basic And Diluted $0.41

Published: 05/04/2021 21:47 GMT
Aquestive Therapeutics Inc (AQST) - Qtrly Net Loss per Share - Basic and Diluted $0.41.
Q1 Revenue $11.1 Million.
Sees 2021 Total Revenues of About $38 Million to $42 Million.
Q1 Earnings per Share View $-0.43, Revenue View $9.0 Million -- Refinitiv Ibes Data (analyst estimates).
FY2021 Revenue View $39.1 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $9.82 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $9.71 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.